October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Ben Ponvilawan: HCC Etiology’s Impact on Positive Results in the CARES-310 Trial
Oct 12, 2024, 14:31

Ben Ponvilawan: HCC Etiology’s Impact on Positive Results in the CARES-310 Trial

Ben Ponvilawan, Doctor of Medicine at UMKC Internal Medicine Residency Program, shared on X:

Our correspondence is now available on The Lancet! Differences in HCC etiology may contribute to the positive result of camrelizumab plus rivoceranib in CARES-310 trial, in contrast to other IO+TKI trials.

Thank you Marc Roth, Saint Luke’s Cancer Institute for the support.”

Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial.

Ben Ponvilawan: HCC Etiology's Impact on Positive Results in the CARES-310 Trial